Home › Funds › Penn Capital Management Company, LLC › TVTX
Penn Capital Management Company, LLC position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
Penn Capital Management Company, LLC reported holding 260,467 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.4M, representing 1.14% of its reported portfolio and ranking #47 among its reported holdings. Penn Capital Management Company, LLC has disclosed TVTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Penn Capital Management Company, LLC's TVTX position evolved
Penn Capital Management Company, LLC first disclosed a stake in TVTX in Q1 2025 at 21,094 shares (US$378K). The position peaked in Q3 2026 at 260,467 shares, worth US$15.4M. Across 7 filings, Penn Capital Management Company, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 260,467 shares valued at US$15.4M — an increase of 245,499 shares quarter over quarter.. Notable position changes include a 40% increase in Q3 2025 (shares rose 60% over the following quarter), a 56% trim in Q4 2025 (shares fell 22% over the following quarter), a 1640% increase in Q3 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 21.09K | $378.00K | New |
| Q2 2025 | 19.32K | $286.00K | Reduce |
| Q3 2025 | 27.00K | $645.40K | Add |
| Q4 2025 | 11.87K | $453.44K | Reduce |
| Q1 2026 | 12.68K | $376.60K | Add |
| Q2 2026 | 14.97K | $850.33K | Add |
| Q3 2026 | 260.47K | $15.35M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- PERCEPTIVE ADVISORS LLC 3.75M sh · $213.18M · Q2 2026
- Rock Springs Capital Management LP 2.18M sh · $123.79M · Q2 2026
- Kynam Capital Management, LP 2.00M sh · $113.62M · Q2 2026
- Stephens Investment Management Group LLC 1.88M sh · $110.50M · Q3 2026
- EMERALD ADVISERS, LLC 1.56M sh · $92.06M · Q3 2026
- Context Capital Management, LLC 62.70M sh · $73.14M · Q3 2026
- MPM BioImpact LLC 1.12M sh · $63.78M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 984.85K sh · $57.99M · Q3 2026
- Jones Hill Capital LP 959.63K sh · $56.50M · Q3 2026
- Eversept Partners, LP 798.97K sh · $45.39M · Q2 2026
- Polar Asset Management Partners Inc. 30.50M sh · $35.91M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 28.00M sh · $32.96M · Q2 2026
More on Penn Capital Management Company, LLC
FAQ
How long has Penn Capital Management Company, LLC held TVTX?
Penn Capital Management Company, LLC has disclosed TVTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Penn Capital Management Company, LLC's current position in TVTX?
As of Q3 2026, Penn Capital Management Company, LLC holds 260.47K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $15.35M, representing 1.14% of its reported portfolio and ranking #47.
Has Penn Capital Management Company, LLC been buying or selling TVTX?
In the latest 13F filing (Q3 2026), Penn Capital Management Company, LLC increased its position in TVTX. The position peaked in Q3 2026 at 260.47K shares.
Which other funds hold TVTX?
Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.